Noteworthy

Feb 01, 2010
Pharmaceutical Executive
As Genentech's Avastin continues to mature and spread its branches, the company is looking for high profits on the back end.
Jan 27, 2010
Pharmaceutical Executive
In a disruptive era of change, old-fashioned intuition still counts.
Jan 22, 2010
By Pharmaceutical Executive Editors
GAO reviews price hikes in branded drugs, FDA opens up to public, and pharma opens its wallet for Haiti. All on this week's Pharma Unplugged.
Jan 20, 2010
Pharmaceutical Executive
Pharm Exec's 2010 crystal ball reveals an industry in upheaval on many fronts. Is going back to the future the answer?
Jan 13, 2010
Pharmaceutical Executive
A new pharma consortium focuses on securing the supply chain upstream. Pharm Exec interviews Rx360 to learn more.
Jan 06, 2010
Pharmaceutical Executive
FDA Commissioner Margaret Hamburg has a history of health advocacy and a clear mandate to transform the agency. But can she succeed where others have failed?
Dec 09, 2009
Pharmaceutical Executive
This year's winning brand advertising campaigns convey compelling messages with eye-catching graphics and creative copy.
Dec 08, 2009
By Pharmaceutical Executive Editors
Alexandra Kibble of Thomson Reuters identifies the products and therapy areas to watch next year.
Nov 18, 2009
Pharmaceutical Executive
The business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot more than just time and money. But is pharma really capable of getting lean?
Nov 11, 2009
Pharmaceutical Executive
Seven Global Trends shaping the future of the pharmaceutical industry.
native1_300x100
lorem ipsum